Anti-Monomeric C-Reactive Protein Antibody Ameliorates Arthritis and Nephritis in Mice

被引:16
作者
Fujita, Chitose [1 ,2 ]
Sakurai, Yasuo [2 ,3 ]
Yasuda, Yuki [3 ]
Takada, Yoshikazu [4 ]
Huang, Cheng-Long [1 ,2 ]
Fujita, Masaaki [1 ,2 ,5 ,6 ]
机构
[1] Kitano Hosp, Div Oncol, Tazuke Kofukai Med Res Inst, Osaka, Japan
[2] Japan Multinatl Trial Org, Nagoya, Aichi, Japan
[3] Canon Med Syst Corp, Otawara, Tochigi, Japan
[4] Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA USA
[5] Kansai Elect Power Hosp, Div Clin Immunol & Rheumatol, Osaka, Japan
[6] Kitano Hosp, Tazuke Kofukai Med Res Inst, Dept Infect Dis, Osaka, Japan
基金
日本学术振兴会;
关键词
BINDING; ALPHA-V-BETA-3; MECHANISMS; DARAPLADIB; ISOFORMS; DISEASE;
D O I
10.4049/jimmunol.2100349
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Conformation-specific Ags are ideal targets for mAb-based immunotherapy. Here, we demonstrate that the monomeric form of C-reactive protein (mCRP) is a specific therapeutic target for arthritis and nephritis in a murine model. Screening of >1800 antimCRP mAb clones identified 3C as a clone recognizing the monomeric, but not polymeric, form of CRP. The anti-mCRP mAb suppressed leukocyte infiltration in thioglycollate-induced peritonitis, attenuated rheumatoid arthritis symptoms in collagen Ab-induced arthritis model mice, and attenuated lupus nephritis symptoms in MRL/Mp-lpr/lpr lupus-prone model mice. These data suggest that the anti-mCRP mAb 3C has therapeutic potential against rheumatoid arthritis and lupus nephritis.
引用
收藏
页码:1755 / 1762
页数:9
相关论文
共 39 条
[1]   SPONTANEOUS MURINE LUPUS-LIKE SYNDROMES - CLINICAL AND IMMUNOPATHOLOGICAL MANIFESTATIONS IN SEVERAL STRAINS [J].
ANDREWS, BS ;
EISENBERG, RA ;
THEOFILOPOULOS, AN ;
IZUI, S ;
WILSON, CB ;
MCCONAHEY, PJ ;
MURPHY, ED ;
ROTHS, JB ;
DIXON, FJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1978, 148 (05) :1198-1215
[2]   C-reactive protein [J].
Black, S ;
Kushner, I ;
Samols, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (47) :48487-48490
[3]   Transitional changes in the CRP structure lead to the exposure of proinflammatory binding sites [J].
Braig, David ;
Nero, Tracy L. ;
Koch, Hans-Georg ;
Kaiser, Benedict ;
Wang, Xiaowei ;
Thiele, Jan R. ;
Morton, Craig J. ;
Zeller, Johannes ;
Kiefer, Jurij ;
Potempa, Lawrence A. ;
Mellett, Natalie A. ;
Miles, Luke A. ;
Du, Xiao-Jun ;
Meikle, Peter J. ;
Huber-Lang, Markus ;
Stark, G. Bjoern ;
Parker, Michael W. ;
Peter, Karlheinz ;
Eisenhardt, Steffen U. .
NATURE COMMUNICATIONS, 2017, 8
[4]   pCRP-mCRP Dissociation Mechanisms as Potential Targets for the Development of Small-Molecule Anti-Inflammatory Chemotherapeutics [J].
Caprio, Vittorio ;
Badimon, Lina ;
Di Napoli, Mario ;
Fang, Wen-Hui ;
Ferris, Glenn R. ;
Guo, Baoqiang ;
Iemma, Rocco S. ;
Liu, Donghui ;
Zeinolabediny, Yasmin ;
Slevin, Mark .
FRONTIERS IN IMMUNOLOGY, 2018, 9
[5]   Phospholipase A2 Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention [J].
Dennis, Edward A. ;
Cao, Jian ;
Hsu, Yuan-Hao ;
Magrioti, Victoria ;
Kokotos, George .
CHEMICAL REVIEWS, 2011, 111 (10) :6130-6185
[6]   C-reactive protein How conformational changes influence inflammatory properties [J].
Eisenhardt, Steffen U. ;
Thiele, Jan R. ;
Bannasch, Holger ;
Stark, G. Bjoern ;
Peter, Karlheinz .
CELL CYCLE, 2009, 8 (23) :3885-3892
[7]  
Fu T, 2002, BIOCHEM J, V366, P195, DOI 10.1042/bj20020045
[8]   Proinflammatory Secreted Phospholipase A2 Type IIA (sPLA-IIA) Induces Integrin Activation through Direct Binding to a Newly Identified Binding Site (Site 2) in Integrins αvβ3, α4β1, and α5β1 [J].
Fujita, Masaaki ;
Zhu, Kan ;
Fujita, Chitose K. ;
Zhao, Min ;
Lam, Kit S. ;
Kurth, Mark J. ;
Takada, Yoko K. ;
Takada, Yoshikazu .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (01) :259-271
[9]   The Binding of Monomeric C-Reactive Protein (mCRP) to Integrins αvβ3 and α4β1 Is Related to Its Pro-Inflammatory Action [J].
Fujita, Masaaki ;
Takada, Yoko K. ;
Izumiya, Yoshihiro ;
Takada, Yoshikazu .
PLOS ONE, 2014, 9 (04)
[10]   Mechanisms of disease: Acute-phase proteins and other systemic responses to inflammation [J].
Gabay, C ;
Kushner, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (06) :448-454